BZKF Translationsgruppe - Determination of residual disease in AML using AI-supported analysis of flow cytometry data (AML-MRD)

Third party funded individual grant


Acronym: AML-MRD

Start date : 01.01.2025

End date : 31.12.2026

Extension date: 31.12.2027

Project details

Involved:

Stefan Krause Project Leader David B. Blumenthal Project Leader Paul Martini Project Member

Contributing FAU Organisations:

Department of Medicine 5 – Haematology and Oncology Professur für Biomedical Network Science

Funding Source

andere Förderorganisation Bayerisches Zentrum für Krebsforschung (BZKF)

Research Areas

Microscope SVG Advanced omics data analysis and applied ML for biomedical data Field of Research